Skip to content

Clinical trials

Observational Urogenital Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Phase: Observational Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20151
20171
20192
20201
20211
20222
20233
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed6
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Wake Forest University Health Sciences2
City of Hope Medical Center1
Duke University1
Icahn School of Medicine at Mount Sinai1
Indiana University1
Inova Health Care Services1
Johns Hopkins University1
M.D. Anderson Cancer Center1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms17
Gastrointestinal Neoplasms8
Urinary Bladder Neoplasms6
Breast Neoplasms5
Lung Neoplasms5
Melanoma5
Neoplasms5
Head and Neck Neoplasms4
Prostatic Neoplasms4
Sarcoma4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.